查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553427

全球神经修復市场规模、份额和趋势分析：按类型、技术、应用、地区和细分市场进行预测（2024-2030）

Neuroprosthetics Market Size, Share & Trends Analysis Report By Type (Motor Prosthetics, Cochlear Implants, Cognitive Prosthetics, Retinal Implants), By Technology, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

神经假体市场成长与趋势：

Grand View Research, Inc.的最新报告显示，2024年至2030年，全球神经修復市场预计将以15.6%的复合年增长率成长，2030年达到349亿美元。神经系统疾病的日益流行，加上对具有成本效益和技术先进的植入的需求，预计将在未来几年扩大对神经假体市场的需求。

此外，与传统药物治疗相关的高成本和副作用也促进了植入的采用。例如，在治疗阿兹海默症、脑动脉瘤和中风时，越来越多地采用迷走神经刺激（VNS）治疗系统而不是抗忧郁症药，这正在推动整体市场的成长。

此外，易患癫痫的老年人口数量不断增加，以及神经移植相对于传统药物治疗的选择正在对整个行业的成长产生积极影响。

神经假体市场报告亮点

  • 2023年的市场占有率将由运动义肢装置领域主导，占比超过42.8.0%，其次是视觉人工电子耳。同时，由于渗透率不断上升以及产品创新方面研发力度的加大，视网膜神经修復术已被确定为成长最快的细分市场之一。
  • 脊髓刺激（SCS）部分占最大份额，超过49.2%，因为SCS疗法用于治疗缺血性疼痛、背部手术失败症候群和复杂难治性疼痛症候群的镇痛特性。此外，它也被应用于透过椎管内和硬膜外微刺激来诱导腿部运动。此外，该领域的技术进步预计将在不久的将来进一步推动市场成长。由于荐椎神经刺激（SNS）在慢性顽固性骨盆疼痛和神经源性膀胱方面的应用，预计将成为预测期内成长最快的领域。
  • 就应用领域而言，由于帕金森氏症和癫痫的增加，运动神经元疾病占据了最大的领域。例如，根据帕金森氏症基金会2012年发布的报告，每年约有6万名美国被诊断出患有帕金森氏症，预计这一数字在预测期内将进一步增加，随着这一细分市场的成长正在蓬勃发展。
  • 2023年，北美占整个神经修復市场的42.5%以上。这是由于神经植入製造商数量众多、研发投资高以及政府和私人机构提供的资金。例如，国防高级研究计划局 (DARPA) 和国家神经病变和中风研究所 (NIH) 与联邦机构合作，提供资金支持进一步开发神经植入的研究和开发倡议。
  • 由于跨国医疗保健的引入以及消费者意识层级的提高，促进安全有效的医疗程序，亚太地区预计将成为成长最快的部分。
  • 由于策略联盟和併购，预计该行业的竞争水平在预测期内仍将保持在高水准。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章神经假体市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 神经假体市场分析工具
    • 波特的分析
    • PESTEL分析

第四章神经假体市场：类型估计和趋势分析

  • 细分仪表板
  • 神经修復市场：类型变化分析（2023/2030）
  • 运动义肢
  • 人工电子耳
  • 认知辅助器具
  • 视网膜植入

第五章神经修復市场：技术评估与趋势分析

  • 细分仪表板
  • 神经修復市场：技术变革分析（2023/2030）
  • 深部脑部刺激（DBS）
  • 迷走神经刺激 (VNS)
  • 脊髓刺激 (SCS)
  • 荐椎神经刺激(SNS)

第六章神经修復市场：应用估算与趋势分析

  • 细分仪表板
  • 神经修復市场：应用变化分析（2023/2030）
  • 运动神经元障碍
    • 帕金森氏症
    • 癫痫
  • 生理障碍
    • 听力障碍
    • 眼科疾病
    • 心臟病
    • 肾臟疾病
  • 认知障碍
    • 阿兹海默症
    • 严重忧郁症

第七章神经修復市场：区域估计与趋势分析

  • 神经修復术市场占有率：按地区划分（2023/2030）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Medtronic Plc
    • LivaNova
    • Cochlear Ltd.
    • Abbott Laboratories
    • Boston Scientific
    • NeuroPace, Inc.
    • St. Jude Medical, Inc.
    • Retina Implant AG.
    • Nervo Corp.
    • Sonova
简介目录
Product Code: 978-1-68038-891-6

Neuroprosthetics Market Growth & Trends:

The global neuroprosthetics market size is expected to reach USD 34.90 billion by 2030, expanding at a CAGR of 15.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand for cost-effective and technologically advanced implants is expected to drive the demand for neuroprosthetics market in the coming years.

In addition, the associated high costs and side effects of conventional medications are responsible for the rising adoption rate of implants. For instance, the increasing adoption of Vagus Nerve Stimulation (VNS) therapy system over therapeutics such as antidepressants in the treatment of Alzheimer's disease, brain aneurysm, and strokes is propelling the overall market growth.

Moreover, the rising geriatric population prone to epilepsy opting for neural implantation over the conventional medication is exerting a positive effect on the overall industry growth.

Neuroprosthetics Market Report Highlights:

  • The motor prosthetic devices segment dominated in terms of revenue share and accounted for over 42.8.0% of the market in 2023, followed by visual cochlear implants. Whereas, retinal neuroprosthetics were identified as one of the fastest growing market segment owing to the rising penetration and the increasing R&D efforts pertaining to product innovation.
  • The Spinal Cord Stimulation (SCS) segment held the largest share at over 49.2% owing to the analgesic property of the SCS therapy used in the treatment of ischemic pain, failed back surgery syndrome, and complex refractory pain syndrome. Furthermore, it finds applications in intraspinal and epidural microstimulation for inducing leg movements. In addition, technological advancements in this segment is expected to further boost market growth in the near future. The sacral Nerve Stimulation (SNS) is expected to be the fastest growing segment over the forecast period due to its applications in chronic intractable pelvic ache and neurogenic bladder.
  • In the applications segment, motor neuron disorders held the largest segment due to the rising incidences of Parkinson's disease and epilepsy. For instance, as per the report published by Parkinson's disease Foundation in 2012, approximately 60,000 Americans were diagnosed with Parkinson's disease each year and the number is expected to grow further over the forecast period thereby fueling this segment's growth.
  • In 2023, North America dominated the overall neuroprosthetics market at over 42.5% owing to the large presence of neural implants manufacturers, higher R&D investments, and the availability of funds from both government and private institutes. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH)in collaboration with the federal agencies are instrumental in providing funds to support R&D initiatives for the further development of neural implants.
  • Asia Pacific is anticipated to be the fastest growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures along with the rising awareness levels amongst consumers
  • Strategic collaborations and mergers & acquisitions are expected to keep the industry rivalry level high over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neuroprosthetics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neuroprosthetics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neuroprosthetics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neuroprosthetics Market: Type Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Motor Prosthetics
    • 4.3.1. Motor Prosthetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cochlear Implants
    • 4.4.1. Cochlear Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Cognitive Prosthetics
    • 4.5.1. Cognitive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Retinal Implants
    • 4.6.1. Retinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neuroprosthetics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neuroprosthetics Market: Technology Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Deep Brain Stimulation (DBS)
    • 5.3.1. Deep Brain Stimulation (DBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Vagus Nerve Stimulation (VNS)
    • 5.4.1. Vagus Nerve Stimulation (VNS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Spinal Cord Stimulation (SCS)
    • 5.5.1. Spinal Cord Stimulation (SCS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Sacral Nerve Stimulation (SNS)
    • 5.6.1. Sacral Nerve Stimulation (SNS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neuroprosthetics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Neuroprosthetics Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Motor Neuron Disorders
    • 6.3.1. Motor Neuron Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Parkinson's Disease
      • 6.3.2.1. Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Epilepsy
      • 6.3.3.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Physiological Disorders
    • 6.4.1. Physiological Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Auditory Disorders
      • 6.4.2.1. Auditory Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Ophthalmic Disorders
      • 6.4.3.1. Ophthalmic Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Cardiac Disorders
      • 6.4.4.1. Cardiac Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Kidney Disorders
      • 6.4.5.1. Kidney Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Cognitive Disorders
    • 6.5.1. Cognitive Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Alzheimer's Disease
      • 6.5.2.1. Alzheimer's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Severe Depression
      • 6.5.3.1. Severe Depression Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Neuroprosthetics Market: Regional Estimates & Trend Analysis

  • 7.1. Neuroprosthetics Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Neuroprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Medtronic Plc
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. LivaNova
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Cochlear Ltd.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Abbott Laboratories
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Boston Scientific
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. NeuroPace, Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. St. Jude Medical, Inc.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Retina Implant AG.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Nervo Corp.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Sonova
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives